DEF 14AThe Ballot
BIOCRYST PHARMACEUTICALS INC files DEF 14A
Filed May 10, 2018 · 8y ago · Accession 0001171843-18-003822
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- DEF 14A
- Filing date
- May 10, 2018
- Report date
- Jun 20, 2018
- Document
- def14a_051018.htm
- Size
- 604 KB